MétaCan
Menu
Back to cohort
Record W4328025841 · doi:10.1055/s-0043-1761792

2-Year Outcomes after Transcatheter Mitral Valve Replacement: Results from the CHOICE-MI Registry

2023· article· en· W4328025841 on OpenAlexaff
Sebastian Ludwig, A. W. Ben, Augustin Coisne, Hendrik Ruge, S. Bleiziffer, J. Weimann, AM Duncan, Gerog Nickenig, Jöerg Hausleiter, M. Adam, Nicholas Dumonteil, Lars Søndergaard, Andrea Garatti, Timo Schmidt, Daniel K. Gry, Taglia Maurizio, T. Walther, Jörg Kempfert, J.F. Obadia, Michael J. Reardon, Martin Andreas, P. Denti, Fabien Praz, Begründet Von, Stefan Blankenberg, H. Reichenspurner, Thomas Modine, Lenard Conradi

Bibliographic record

VenueThe Thoracic and Cardiovascular Surgeon · 2023
Typearticle
Languageen
FieldMedicine
TopicCardiac Valve Diseases and Treatments
Canadian institutionsMontreal Heart Institute
Fundersnot available
KeywordsMitral regurgitationMedicineMitral valve replacementCardiologyInternal medicineMulticenter studyMitral valveRandomized controlled trial

Abstract

fetched live from OpenAlex

All articles of this category Background: Transcatheter mitral valve replacement (TMVR) using dedicated devices is an alternative therapy for high-risk patients with mitral regurgitation (MR). This study aimed to assess 2-year outcomes and predictors of mortality in patients undergoing TMVR from the CHOICE-MI multicenter registry. Method: The CHOICE-MI registry included consecutive patients with symptomatic MR treated with 11 different dedicated TMVR devices at 31 international centers. Investigated endpoints included mortality and heart failure hospitalization rates, procedural complications, residual MR, and functional status. Multivariable Cox regression analysis was applied to identify independent predictors of 2-year mortality. Results: A total of 400 patients (age: 76 years [IQR: 71, 81], 59.5% male, EuroSCORE II: 6.2% [3.8, 12.0]) underwent TMVR. Technical success was achieved in 95.2% of patients. MR reduction to ≤1+ was observed in 95.2% at discharge with durable results at 1 and 2 years. Functional class improved significantly at 1 and 2 years. All-cause mortality rates were 9.2% at 30 days, 27.9% at 1 year, and 38.1% at 2 years after TMVR. Chronic obstructive pulmonary disease, reduced glomerular filtration rate, and low serum albumin were independent predictors of 2-year mortality. Among 30-day complications, left ventricular outflow tract obstruction, access site, and bleeding complications showed the strongest impact on 2-year mortality. Conclusion: In this real-world registry of patients with symptomatic MR undergoing TMVR, treatment with TMVR was associated with durable resolution of MR and significant functional improvement at 2 years. Two-year mortality was 38%. Optimized patient selection and improved access site management are mandatory to improve outcomes. Publication History Article published online: 28 January 2023 © 2023. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.003
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.003
Threshold uncertainty score0.007

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.003
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0010.001
Open science0.0010.001
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.019
GPT teacher head0.304
Teacher spread0.285 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2023
Admission routes1
Has abstractyes

Explore more

Same venueThe Thoracic and Cardiovascular SurgeonSame topicCardiac Valve Diseases and TreatmentsFrench-language works237,207